Helmholtz Gemeinschaft


Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons

Item Type:Article
Title:Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons
Creators Name:Stumpf, A., Parthier, D., Sammons, R.P., Stempel, A.V., Breustedt, J., Rost, B.R. and Schmitz, D.
Abstract:Endogenous cannabinoids are diffusible lipid ligands of the main cannabinoid receptors type 1 and 2 (CB(1)R and CB(2)R). In the central nervous system endocannabinoids are produced in an activity-dependent manner and have been identified as retrograde modulators of synaptic transmission. Additionally, some neurons display a cell-autonomous slow self-inhibition (SSI) mediated by endocannabinoids. In these neurons, repetitive action potential firing triggers the production of endocannabinoids, which induce a long-lasting hyperpolarization of the membrane potential, rendering the cells less excitable. Different endocannabinoid receptors and effector mechanisms have been described underlying SSI in different cell types and brain areas. Here, we investigate SSI in neurons of layer 2/3 in the somatosensory cortex. High-frequency bursts of action potentials induced SSI in pyramidal cells (PC) and regular spiking non-pyramidal cells (RSNPC), but not in fast-spiking interneurons (FS). In RSNPCs the hyperpolarization was accompanied by a change in input resistance due to the activation of G protein-coupled inward-rectifying K(+) (GIRK) channels. A CB(2)R-specific agonist induced the long-lasting hyperpolarization, whereas preincubation with a CB(2)R-specific inverse agonist suppressed SSI. Additionally, using cannabinoid receptor knockout mice, we found that SSI was still intact in CB(1)R-deficient but abolished in CB(2)R-deficient mice. Taken together, we describe an additional SSI mechanism in which the activity-induced release of endocannabinoids activates GIRK channels via CB(2)Rs. These findings expand our knowledge about cell type-specific differential neuronal cannabinoid receptor signaling and suggest CB(2)R-selective compounds as potential therapeutic approaches.
Keywords:Cannabinoid Receptor Type 2, Electrophysiology, Endocannabinoids, Somatosensory Cortex, Slow Self-Inhibition, Animals, Mice
Publisher:Elsevier / Pergamon
Page Range:217-225
Date:1 September 2018
Additional Information:Copyright © 2018 Elsevier Ltd. All rights reserved.
Official Publication:https://doi.org/10.1016/j.neuropharm.2018.07.020
External Fulltext:View full text on external repository or document server
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library